2020 ALS ONE Virtual Research Symposium

Nov

4

to

Nov

5

2020 ALS ONE Virtual Research Symposium

The 2020 ALS ONE Symposium is Going Virtual!

ALS ONE's annual ALS ONE Research Symposium, hosted by Drs. Robert Brown, James Berry, Merit Cudkowicz, and Steve Perrin of ALS ONE, brings together researchers and scientists who are working on therapeutic options, and ultimately a cure, for Amyotrophic Lateral Sclerosis (ALS). This year’s topics are comprised of some of the most exciting updates on new and important disease topics in ALS, including:

- From Sporadic ALS (SALS) to Familial ALS (FALS): New biology and therapeutic opportunities.
- New insights into axonal trafficking and MN's.

- Updates from industry
- HEALEY ALS Platform Trial updates roundtable discussion.

November 4-5, 2020 10:30am-3:30pm EST each day | Open to all ALS researchers and scientists.

Attendance is free | Registration is required.

Register Now

ALS ONE invites you to join us virtually for 2 days of sharing and collaboration.

Merit Cudkowicz, MD, MSc

Robert Brown, MD, DPhil

James Berry, MD, MPH

Steven Perrin, Ph.D.

ALS ONE's annual ALS ONE Research Symposium, hosted by Drs. Robert Brown, James Berry, Merit Cudkowicz, and Steve Perrin of ALS ONE, brings together researchers and scientists who are working on therapeutic options, and ultimately a cure, for Amyotrophic Lateral Sclerosis (ALS). This year’s topics are comprised of some of the most exciting updates on new and important disease topics in ALS, including:

- From Sporadic ALS (SALS) to Familial ALS (FALS): New biology and therapeutic opportunities.
- New insights into axonal trafficking and MN's.
- HEALEY ALS Platform Trial updates roundtable discussion.

Keynote Speakers

Merit Cudkowicz, MD

Chief of Neurology Massachusetts General Hospital
Julieanne Dorn Professor of Neurology Harvard Medical School
DIrector Sean M. Healey & AMG Center for ALS at Mass General Hospital

Kevin Eggan, PhD

Professor in the Department of Stem Cell and Regenerative Biology at Harvard University, Director of Stem Cell Biology for the Stanley Center for Psychiatric Research at the Broad Institute

Aaron Gitler, PhD

BASIC SCIENCE PROFESSOR Genetics, STANFORD MEDICINE

Erika Holzbaur, PhD

William Maul Measey Professor of Physiology, University of Pennsylvania Perelman School of Medicine

Clotilde Lagier-Tourenne, MD, PhD

Associate Professor of Neurology, Harvard Medical School
Associate in Neuroscience, Massachusetts General Hospital
Healey Family ALS Endowed Chair for Research

Nicholas John Maragakis, M.D.

Director of the ALS Center for cell therapy and regeneration research, co-director of the johns hopkins als clinic and professor of neurology at johns hopkins university

Dorothy (Dori) Schafer, PhD

Assistant Professor
Ineurobiology, University of Massachusetts Medical School
Department

Jeremy Shefner, MD, PhD

kemper and ethel marley chair of neurology and associate director for barrow neurological institute

Michael Ward, MD, PhD

Principal INVESTIGATOR,
INHERITED NEURODEGENERATIVE DISEASES UNIT, NINDS

November 4th: Day 1 Agenda

10:30 – 10:45 AM

Welcome & Introductions

10:45 – 12:45 AM

From SALS to FALS: New biology and therapeutic opportunities

(Talk titles to come)

12:45 – 1:15 PM

Break

1:15 – 2:15 PM

Trial Updates

2:15 – 3:15 PM

New insights into axonal trafficking and MNs

(Talk titles to come)

10:30 – 10:45 AM

Welcome & Introductions

10:45 – 12:45 AM

Industry Updates

12:45 – 1:00 PM

Break

1:00 – 2:00 PM

Industry Updates

2:00 – 4:00 PM

HEALEY ALS Platform Trial Zoom Round Table Discussion

Frequently Asked Questions

Connecting to the meeting?

Q: How do I connect to the meeting?

A: The Zoom meeting link will be posted on this site and sent out to registered meeting attendees no later than 2 weeks prior to the meeting.

Invitees

Q: I would like others from my company to join. How do I go about that?

A: We would love to have them attend! Simply send them the link to register and have them complete the online registration. The symposium is open to researchers and scientists in the ALS industry.

Sponsors

Q: My company would like to become a sponsor. How might we go about that?

A: We would be so grateful for your support! Please contact Jennifer DiMartino, Executive Director of ALS ONE to learn more about sponsorship packages. She can be reached at: jen@alsone.org

Venue

The health and safety of our members, speakers, and Annual Meeting attendees is our number one priority. After careful consideration, in light of the COVID-19 pandemic’s current trajectory, we’ve made the decision to transition to a fully virtual event.

More details to come.

About ALS ONE

ALS ONE is where research and care unite in the fight against ALS.

ALS ONE is a partnership bringing together world-leading ALS researchers, doctors, and care practitioners focused on finding treatments for ALS and novel approaches to improve care and quality of life for those battling the disease. The unprecedented linking of minds and resources from Massachusetts General Hospital (MGH), University of Massachusetts Medical Center, ALS Therapy Development Institute (ALS TDI), and Compassionate Care ALS (CCALS) is unique for its leadership in efficiency, dedication to innovative research, and commitment to increasing access to care and treatment.

ALS ONE's partnership includes: Dr. Merit Cudkowicz, MD, MSc, Chief of Neurology, Massachusetts General Hospital (MGH); Dr. Robert Brown Jr., MD, DPhil, Chief of Neurology, UMass Medical Center; Dr. Steve Perrin, Ph.D., Chief Science Officer, ALS Therapy Development Institute; Dr. James Berry, MD, Co-Director of the MGH Neuromuscular Division and of the MGH ALS Unit; and Ron Hoffman, Founder and Director Compassionate Care ALS (CCALS).

Learn more about ALS ONE online at ALS ONE.org

THE 2020 ALS ONE RESEARCH SYMPOSIUM IS GENEROUSLY SPONSORED BY

GOLD sponsors

BRONZE sponsors

Our Partners